Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | — | 16.1B | 10.1B | 8.1B |
Cost of revenue | — | 13.8B | 8.6B | 7.0B |
Gross profit | — | 2.3B | 1.5B | 1.1B |
Operating expense | ||||
Research & development | — | 2.0B | 1.6B | 1.5B |
Selling general and admin | — | 2.3B | 1.6B | 1.6B |
Other operating expenses | — | -196.4M | -39.9M | -278.8M |
Operating income | — | -1.8B | -1.7B | -1.6B |
Non operating interest income | ||||
Income | — | 301.2M | 318.0M | 356.7M |
Expense | — | 94.0M | 83.5M | 81.4M |
Other income expense | 112.1M | 203.8M | -324.9M | 5.2M |
Pretax income | — | -1.3B | -1.8B | -1.3B |
Tax provision | 8.0M | -44.1M | 7.0M | -33.8M |
Net income | — | -1.3B | -1.8B | -1.3B |
Basic EPS | — | — | -1.0 | -0.7 |
Diluted EPS | — | — | -1.0 | -0.7 |
Basic average shares | — | — | 1.9B | 1.9B |
Diluted average shares | — | — | 1.9B | 1.9B |
EBITDA | — | -1.4B | -1.4B | -1.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |